145 related articles for article (PubMed ID: 26161142)
1. A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer.
Gil T; Aoun F; Cabri P; Maisonobe P; van Velthoven R
Ther Adv Urol; 2015 Jun; 7(3):116-24. PubMed ID: 26161142
[TBL] [Abstract][Full Text] [Related]
2. Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.
Gil T; Aoun F; Cabri P; Perrot V; van Velthoven R
Ther Adv Urol; 2017 Jul; 9(7):179-190. PubMed ID: 28747996
[TBL] [Abstract][Full Text] [Related]
3. Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study.
He LY; Zhang M; Chen ZW; Yuan JL; Ye DW; Ma LL; Wei H; Yang JG; Chen S; Wan B; Xia SJ; Weng ZL; Kong XB; Wei Q; Jin FS; Zhang XH; Qian WQ; Wang SS; Chen YH; Ma HS; Sun YH; Gao X
BMC Urol; 2018 Mar; 18(1):23. PubMed ID: 29587718
[TBL] [Abstract][Full Text] [Related]
4. [Study of the beneficial effects of triptorelin on lower urinary tract symptoms in Algeria in patients with non-localized prostate cancer].
Hachi K; Boualga K; Chettibi K; Harouni M; Ounnoughene M; Bekkat-Berkani N; Maisonobe P; Yousfi MJ
Prog Urol; 2018 Jun; 28(8-9):450-459. PubMed ID: 29789236
[TBL] [Abstract][Full Text] [Related]
5. Triptorelin therapy for lower urinary tract symptoms (LUTS) in prostate cancer patients: A systematic meta-analysis.
Barrett R; Birch B
BJUI Compass; 2024 Jan; 5(1):17-28. PubMed ID: 38179030
[TBL] [Abstract][Full Text] [Related]
6. Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients.
Woo HH; Murphy DG; Testa GM; Grummet JP; Chong M; Stork AP
Res Rep Urol; 2017; 9():27-35. PubMed ID: 28261572
[TBL] [Abstract][Full Text] [Related]
7. Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study.
Peltier A; Aoun F; De Ruyter V; Cabri P; Van Velthoven R
Prostate Cancer; 2015; 2015():978194. PubMed ID: 25694830
[TBL] [Abstract][Full Text] [Related]
8. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study.
Morote J; Gómez-Caamaño A; de Celis RP; Gómez-Veiga F; Ciria JP; Calleja J; Extramiana J; Pérez-Sampietro M; Perrot V; Angulo JC;
Neurourol Urodyn; 2022 Nov; 41(8):1824-1833. PubMed ID: 36069170
[TBL] [Abstract][Full Text] [Related]
9. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
Martínez-Piñeiro L; Schalken JA; Cabri P; Maisonobe P; de la Taille A;
BJU Int; 2014 Oct; 114(4):608-16. PubMed ID: 24806330
[TBL] [Abstract][Full Text] [Related]
11. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.
Axcrona K; Aaltomaa S; da Silva CM; Ozen H; Damber JE; Tankó LB; Colli E; Klarskov P
BJU Int; 2012 Dec; 110(11):1721-8. PubMed ID: 22500884
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer.
Lebret T; Rouanne M; Hublarov O; Jinga V; Petkova L; Kotsev R; Sinescu I; Dutailly P
Ther Adv Urol; 2015 Jun; 7(3):125-34. PubMed ID: 26161143
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
BJU Int; 2019 Jul; 124(1):27-34. PubMed ID: 30681264
[TBL] [Abstract][Full Text] [Related]
15. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.
Zhang T; Wu H; Liu S; He W; Ding K
Int Urol Nephrol; 2017 Jul; 49(7):1111-1117. PubMed ID: 28409402
[TBL] [Abstract][Full Text] [Related]
17. Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled Analysis.
Mason M; Richaud P; Bosnyak Z; Malmberg A; Neijber A
Low Urin Tract Symptoms; 2017 May; 9(2):82-88. PubMed ID: 28394498
[TBL] [Abstract][Full Text] [Related]
18. Lower urinary tract symptoms and their severity in men subjected to prostate biopsy.
Dobruch J; Modzelewska E; Tyloch J; Misterek B; Czapkowicz E; Bres-Niewada E; Borówka A
Cent European J Urol; 2014; 67(2):177-81. PubMed ID: 25140233
[TBL] [Abstract][Full Text] [Related]
19. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
[TBL] [Abstract][Full Text] [Related]
20. Lower Urinary Tract Symptoms and Urinary Bother Are Common in Patients Undergoing Elective Cervical Spine Surgery.
Lieberman EG; Radoslovich S; Marshall LM; Yoo JU
Clin Orthop Relat Res; 2019 Apr; 477(4):872-878. PubMed ID: 30844824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
